Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
Clinical trial NCT04378543 · UNKNOWN
Trial details
- NCT number
- NCT04378543
- Sponsor
- Ankasa Regenerative Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2022-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.